A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers
<p><strong>Background</strong></p><p>Despite much progress in cancer research, its incidence and mortality continue to rise. A robust biomarker that would predict tumor behavior is highly desirable and could improve patient treatment and prognosis.</p><p><...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2019
|